[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Deng et al., 2022 - Google Patents

Pre-administration of berberine exerts chemopreventive effects in AOM/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and …

Deng et al., 2022

View HTML
Document ID
932659306244460278
Author
Deng J
Zhao L
Yuan X
Li Y
Shi J
Zhang H
Zhao Y
Han L
Wang H
Yan Y
Zhao H
Wang H
Zou F
Publication year
Publication venue
Nutrients

External Links

Snippet

Inflammatory activation and intestinal flora imbalance play an essential role in the development and progression of colorectal cancer (CRC). Berberine (BBR) has attracted great attention in recent years due to its heath-related benefits in inflammatory disorders and …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Deng et al. Pre-administration of berberine exerts chemopreventive effects in AOM/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota
Tong et al. Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis mice
Suo et al. Lactobacillus fermentum Suo attenuates HCl/ethanol induced gastric injury in mice through its antioxidant effects
Perillo et al. Gut microbiota manipulation as a tool for colorectal cancer management: recent advances in its use for therapeutic purposes
Chang et al. Modulation of gut microbiota combined with upregulation of intestinal tight junction explains anti-inflammatory effect of corylin on colitis-associated cancer in mice
Dikeocha et al. Faecalibacterium prausnitzii ameliorates colorectal tumorigenesis and suppresses proliferation of HCT116 colorectal cancer cells
Georgiou et al. Gut microbiota in lung cancer: where do we stand?
Kaźmierczak-Siedlecka et al. Gut microbiota modulation in the context of immune-related aspects of Lactobacillus spp. and Bifidobacterium spp. in gastrointestinal cancers
Yeo et al. Anti-inflammatory and gut microbiota modulatory effect of Lactobacillus rhamnosus strain LDTM 7511 in a dextran sulfate sodium-induced colitis murine model
Wang et al. Alleviation effects of Bifidobacterium animalis subsp. lactis XLTG11 on dextran sulfate sodium-induced colitis in mice
Lee et al. Synbiotic combination of Djulis (Chenopodium formosanum) and Lactobacillus acidophilus inhibits colon carcinogenesis in rats
Garcia et al. Effects of vitamin D supplementation on inflammation, colonic cell kinetics, and microbiota in colitis: a review
Alkushi et al. Multi-strain-probiotic-loaded nanoparticles reduced Colon inflammation and orchestrated the expressions of tight junction, NLRP3 Inflammasome and Caspase-1 genes in DSS-induced colitis model
Kangwan et al. Protective effect of probiotics isolated from traditional fermented tea leaves (Miang) from Northern Thailand and role of synbiotics in ameliorating experimental ulcerative colitis in mice
Liu et al. Interaction of gut microbiota with endocrine homeostasis and thyroid cancer
Liu et al. Preventive effect of Lactobacillus fermentum CQPC08 on 4-nitroquineline-1-oxide induced tongue cancer in C57BL/6 mice
Valadez-Bustos et al. Oral administration of microencapsulated B. Longum BAA-999 and lycopene modulates IGF-1/IGF-1R/IGFBP3 protein expressions in a colorectal murine model
Zhang et al. Lacticaseibacillus rhamnosus Probio-M9-driven mouse mammary tumor-inhibitory effect is accompanied by modulation of host gut microbiota, immunity, and serum metabolome
Zhang et al. Short-term lincomycin exposure depletion of murine microbiota affects short-chain fatty acids and intestinal morphology and immunity
Wu et al. Indole-3-carbinol inhibits Citrobacter rodentium infection through multiple pathways including reduction of bacterial adhesion and enhancement of cytotoxic T cell activity
Brandi et al. The human microbiomes in pancreatic cancer: Towards evidence-based manipulation strategies?
Dikeocha et al. Investigation into the potential role of Propionibacterium freudenreichii in prevention of colorectal cancer and its effects on the diversity of gut microbiota in rats
Najafi et al. Prophylactic vs. therapeutic effect of probiotics on the inflammation mediated by the NF-κb pathway in inflammatory bowel conditions
Cuomo et al. Gut microbiota host–gene interaction
Shi et al. Protective effect of Lactiplantibacillus plantarum subsp. plantarum SC-5 on dextran sulfate sodium—induced colitis in mice